Sterling Pharma Solutions has commenced production of hydroxychloroquine (HCQ), a treatment currently under investigation for COVID-19. Read more...
Mylan announced a global collaboration with Gilead Sciences to expand access to the investigational antiviral remdesivir for the potential treatment of COVID-19. Read more...
Parexel unveiled its COVID-19 Risk Mitigation offering, which leverages the company’s experience with global viral outbreaks as well as cGMP inspection and CMC review processes to ensure that manufacturers can safely and confidently continue operations through the COVID-19 pandemic. Read more...
To accelerate the development of safe and effective COVID-19 vaccines, medicines and other treatments, the U.S. Pharmacopeia (USP) has launched a new program to support scientists, developers and manufacturers worldwide. Read more...